{
    "version": "1.0",
    "type": "rich",
    "width": "",
    "height": "",
    "title": "Boehringer Ingelheim ja Lilly annavad teada positiivsetest tulemustest olulises III faasi uuringus, kus hinnati empagliflosiini lisamist insuliinile 1. tüüpi suhkurtõvega patsientidel",
    "url": "https://www.med24.ee/partnerite-uudised/boehringer-ingelheim-ja-lilly-annavad-teada-positiivsetest-tulemustest-olulises-iii-faasi-uuringus-kus-hinnati-empagliflosiini-lisamist-insuliinile-1-tueuepi-suhkurtovega-patsientidel/428575",
    "author_name": "med24",
    "author_url": "https://www.med24.ee",
    "provider_name": "Labrador",
    "provider_url": "http://www.labradorcms.com/",
    "html": "<div class=\"labrador-cms-embed\" data-lab-style=\" dac-embed-full\" data-lab-content=\"full\" data-lab-id=\"428575\" data-lab-site=\"www.med24.ee\"><script async defer src=\"https://www.med24.ee/embed.js?v=335\"></script></div>"
}